Wednesday, July 8, 2026

pharma · Duchenne Muscular Dystrophy · Duchenne Muscular Dystrophy (DMD) · TRDA

Entrada Therapeutics

News and analysis for Entrada Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

Boston, USA HQ
2016 Founded
201 Employees
Public company Type
TRDA · NYSE Ticker
Company details
Status
Public
HQ
Boston, USA
Founded
2016
Employees
201
Programs
4
Drugs
4
Patents
5
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Entrada Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Entrada Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Entrada Therapeutics yet.

Back to company overview →